Sustaining excessive nitric oxide upregulates protein expression of nitric oxide synthase via soluble guanylyl cyclase: An in vivo study in rats

Journal of Cardiovascular Pharmacology

Volumn 44, Issue 1, 2004, Pages 42-49

  Kagota, Satomi ^a   Yamaguchi, Yu ^a   Nakamura, Kazuki ^a   Shinozuka, Kazumasa ^a   Kunitomo, Masaru ^a  

^a MUKOGAWA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Endothelial nitric oxide synthase; Lipopolysaccharide; Nitric oxide; Soluble guanylyl cyclase

Indexed keywords

ACETYLCHOLINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GUANYLATE CYCLASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; NOX 100; SCAVENGER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL FUNCTION; CONTROLLED STUDY; DOWN REGULATION; ENZYME REGULATION; IN VIVO STUDY; MALE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; BLOTTING, WESTERN; GUANYLATE CYCLASE; INJECTIONS, INTRAPERITONEAL; LIPOPOLYSACCHARIDES; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE; RATS; RATS, WISTAR; VASODILATION;

EID: 3042781156     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200407000-00006     Document Type: Article

References (27)

1. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991;43:109-142.
2. Kagota S, Tamashiro A, Yamaguchi Y, et al. Downregulation of vascular soluble guanylate cyclase induced by high salt intake in spontaneously hypertensive rats. Br J Pharmacol. 2001;134:737-744.
3. Kagota S, Tamashiro A, Yamaguchi Y, et al. High salt intake impairs vascular nitric oxide/cyclic guanosine monophosphate system in spontaneously hypertensive rats. J Pharmacol Exp Ther. 2002;302:344-351.
4. Andreopoulos S, Papapetropoulos A. Molecular aspects of soluble guanylyl cyclase regulation. Gen Pharmacol. 2000;34:147-157.
5. Parratt JR. Nitric oxide in sepsis and endotoxaemia. J Antimicrob Chemother. 1998;41:A31-A39.
6. Papapetropoulos A, Abou-Mojamed G, Marczin N, et al. Downregulation of nitrovasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1beta. Br J Pharmacol. 1996;118:1359-1366.
7. Papapetropoulos A, Go VY, Murad F, et al. Mechanisms of tolerance to sodium nitroprusside in rat cultured aortic smooth muscle cells. Br J Pharmacol. 1996;117:147-155.
8. Dickinson E, Tuncer P, Nadler E, et al. NOX, a novel nitric oxide scavenger, reduces bacterial transaction in rats after endotoxin challenge. Am J Physiol. 1999;277:G1281-G1287.
9. Nadler EP, Dickinson EC, Beer-Stolz D, et al. Scavenging nitric oxide reduces hepatocellular injury after endotoxin challenge. Am J Physiol Gastrointest Liver Physiol. 2001;281:G173-G181.
10. Szabo C, Thiemermann C, Wu C-C, et al. Attenuation of the induction of nitric oxide synthase by endogeneous glucocorticoids accounts for endotoxin tolerance in vivo. Proc Natl Acad Sci U S A. 1994;91:271-275.
11. Chang CC, McCormick CC, Lin AW, et al. Inhibition of nitric oxide synthase gene expression in vivo and in vitro by repeated doses of endotoxin. Am J Physiol. 1996;271:G539-G548.
12. Pieper GM, Dembny K, Siebeneich W. Long-term treatment in vivo with NOX-101, a scavenger of nitric oxide, prevents diabetes-induced endothelial dysfunction. Diabetologia. 1998;41:1220-1226.
13. Guevara I, Iwanejko J, Dembinska-Kiec A, et al. Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin Chim Acta. 1998;274:177-188.
14. Lai C-S, Komarov AM. Spin trapping of nitric oxide produced in vivo in septic-chock mice. FEBS Lett. 1994;345:120-124.
15. Scott WS, Nakayama DK. Escherichia coli lipopolysaccharide downregulates soluble guanylate cyclase in pulmonary artery smooth muscle. J Surg Res. 1998;80:309-314.
16. Yamashita T, Kawashima S, Ohashi Y, et al. Mechanisms of reduced nitric oxide/cGMP-mediated vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. Hypertension. 2000;36:97-102.
17. Brandes RP, Koddenberg G, Gwinner W, et al. Role of increased production of superoxide anions by NAD(P)H oxidase and xanthin oxidase in prolonged endotoxemia. Hypertension. 1999;33:1243-1249.
18. Mülsch A, Oelze M, Klöss S, et al. Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aorta. Circulation. 2001;103:2188-2194.
19. Pu Q, Bordet R, Robin E, et al. Low dose of lipopolysaccharide induces a delayed enhanced nitric oxide-mediated relaxation in rat aorta. Eur J Pharmacol. 1999;377:209-214.
20. Castillo DD, Agarwal A, Jaimes EA, et al. Glomerular and vascular tissues do not down-regulate nitric oxide synthesis during protracted endotoxemia. Kidney Int. 1997;52:460-467.
21. Münzel T, Li H, Mollnau H, et al. Effects of long-term nitroglycerin treatment on endothelial nitric oxide synthase (NOS III) gene expression, NOS III-mediated superoxide production, and vascular NO bioavailability. Circ Res. 2000;86:e7-12.
22. Lu JL, Schmiege LM 3rd, Kuo L, et al. Downregulation of endothelial constitutive nitric oxide synthase expression by lipopolysaccharide. Biochem Biophys Res Commun. 1996;225:1-5.
23. Yoshizumi M, Perrella MA, Butnett JC Jr, et al. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res. 1993;73:205-209.
24. Vaziri ND, Wang XQ. cGMP-mediated negative-feedback regulation of endothelial nitric oxide synthase expression by nitric oxide. Hypertension. 1999;34:1237-1241.
25. Li H, Wallerath T, Förstermann U. Physiological mechanisms regulating the expression of endothelial-type NO synthase. Nitric Oxide. 2002;7:132-147.
26. Li H, Wallerath T, Münzel T, et al. Regulation of endothelial-type N synthase expression in pathophysiology and in response to drugs. Nitric Oxide. 2002;7:149-164.
27. Brandes PR, Kim D, Schmitz-Winnenthal FH, et al. Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knockout mice: role of soluble guanylyl cyclase. Hypertension. 2000;35:231-236.